TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,207 | +171.6% | 789 | +175.9% | 0.00% | – |
Q2 2023 | $4,494 | -4.7% | 286 | 0.0% | 0.00% | – |
Q1 2023 | $4,714 | -22.7% | 286 | -26.9% | 0.00% | – |
Q4 2022 | $6,100 | +52.5% | 391 | +36.7% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 286 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 286 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -71.4% | 286 | -72.3% | 0.00% | – |
Q4 2021 | $14,000 | -17.6% | 1,031 | 0.0% | 0.00% | – |
Q3 2021 | $17,000 | 0.0% | 1,031 | 0.0% | 0.00% | – |
Q2 2021 | $17,000 | -10.5% | 1,031 | -1.0% | 0.00% | -100.0% |
Q1 2021 | $19,000 | 0.0% | 1,041 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $19,000 | 0.0% | 1,041 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $19,000 | 0.0% | 1,041 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $19,000 | +18.8% | 1,041 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $16,000 | -36.0% | 1,041 | -19.4% | 0.00% | 0.0% |
Q4 2019 | $25,000 | -55.4% | 1,292 | -60.5% | 0.00% | -50.0% |
Q3 2019 | $56,000 | -30.0% | 3,273 | -27.4% | 0.00% | -33.3% |
Q2 2019 | $80,000 | – | 4,509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |